tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AU:PTX Stock Latest News

Prescient Therapeutics Announces New Office Location Amidst Strategic Growth
Company AnnouncementsPrescient Therapeutics Announces New Office Location Amidst Strategic Growth
11d ago
PTX
Prescient Therapeutics Advances with Phase 2A Trial of PTX-100
PremiumCompany Announcements
Prescient Therapeutics Advances with Phase 2A Trial of PTX-100
15d ago
PTX
Prescient Therapeutics Advances PTX-100 in Phase 2a Study for CTCL
PremiumCompany Announcements
Prescient Therapeutics Advances PTX-100 in Phase 2a Study for CTCL
17d ago
PTX
Prescient Therapeutics Highlights Forward-Looking Risks in Cancer Therapy Development
PremiumCompany Announcements
Prescient Therapeutics Highlights Forward-Looking Risks in Cancer Therapy Development
23d ago
PTX
Prescient Therapeutics Director Increases Stake
PremiumCompany Announcements
Prescient Therapeutics Director Increases Stake
1M ago
PTX
Director’s Acquisition Signals Confidence in Prescient Therapeutics
PremiumCompany AnnouncementsDirector’s Acquisition Signals Confidence in Prescient Therapeutics
1M ago
PTX
Prescient Therapeutics Advances PTX-100 Study and Appoints New Board Chair
Premium
Company Announcements
Prescient Therapeutics Advances PTX-100 Study and Appoints New Board Chair
2M ago
PTX
Prescient Therapeutics Advances Cancer Therapy with FDA Fast Track
Premium
Company Announcements
Prescient Therapeutics Advances Cancer Therapy with FDA Fast Track
2M ago
PTX
Prescient Therapeutics’ PTX-100 Gains FDA Fast Track Status
PremiumCompany Announcements
Prescient Therapeutics’ PTX-100 Gains FDA Fast Track Status
2M ago
PTX
Prescient Therapeutics Appoints Melanie Farris as Non-Executive Director
PremiumCompany Announcements
Prescient Therapeutics Appoints Melanie Farris as Non-Executive Director
2M ago
PTX
Prescient Therapeutics to Host Investor Briefing on PTX-100 Progress
PremiumCompany Announcements
Prescient Therapeutics to Host Investor Briefing on PTX-100 Progress
2M ago
PTX
Prescient Therapeutics Initiates First Clinical Site for PTX-100 Phase 2a Study
PremiumCompany Announcements
Prescient Therapeutics Initiates First Clinical Site for PTX-100 Phase 2a Study
3M ago
PTX
Prescient Therapeutics Appoints New Chief Medical Officer to Drive Cancer Therapy Innovations
PremiumCompany AnnouncementsPrescient Therapeutics Appoints New Chief Medical Officer to Drive Cancer Therapy Innovations
3M ago
PTX
Prescient Therapeutics Director Increases Shareholding
Premium
Company Announcements
Prescient Therapeutics Director Increases Shareholding
3M ago
PTX
Prescient Therapeutics Announces New Board Chair Amidst Growth Phase
Premium
Company Announcements
Prescient Therapeutics Announces New Board Chair Amidst Growth Phase
3M ago
PTX
Prescient Therapeutics Reports Decreased Losses Amid Revenue Drop
PremiumCompany Announcements
Prescient Therapeutics Reports Decreased Losses Amid Revenue Drop
4M ago
PTX
Prescient Therapeutics Initiates Phase 2 Trial and Strengthens Leadership
PremiumCompany Announcements
Prescient Therapeutics Initiates Phase 2 Trial and Strengthens Leadership
4M ago
PTX
Prescient Therapeutics Overcomes OmniCAR Technical Challenges to Advance Cancer Treatment
PremiumCompany Announcements
Prescient Therapeutics Overcomes OmniCAR Technical Challenges to Advance Cancer Treatment
5M ago
PTX
Prescient Therapeutics Issues Unquoted Equity Securities
PremiumCompany Announcements
Prescient Therapeutics Issues Unquoted Equity Securities
5M ago
PTX
Prescient Therapeutics Reports Expiry of 1 Million Options
PremiumCompany AnnouncementsPrescient Therapeutics Reports Expiry of 1 Million Options
5M ago
PTX
Prescient Therapeutics Gains FDA Approval for PTX-100 Trial
Premium
Company Announcements
Prescient Therapeutics Gains FDA Approval for PTX-100 Trial
6M ago
PTX
Prescient Therapeutics Appoints New CEO for Growth
Premium
Company Announcements
Prescient Therapeutics Appoints New CEO for Growth
6M ago
PTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >